Indonesia retail pharmacy market is expanding rapidly, supported by over 40,000 outlets across the country. The market is valued at around USD 5.9 billion and is driven by increasing demand for over-the-counter (OTC) medicines, rising chronic disease incidence, and growing healthcare awareness among the population.

The government’s universal healthcare initiative has significantly improved access to affordable medicines, boosting the retail pharmacy sector. Despite its size, the market remains largely fragmented, with organized pharmacy chains accounting for a small share. This presents a substantial growth opportunity for consolidation and the expansion of branded pharmacy chains.

Digital transformation is also reshaping the market. E-pharmacies and online platforms are offering prescription refills, doorstep delivery, and health consultations, enhancing consumer convenience. The rise of chronic conditions such as diabetes and hypertension has increased the frequency of pharmacy visits, especially in urban centers.

Leading pharmacy chains are actively expanding their store networks and integrating digital health services to capture a larger share of the market. With supportive healthcare policies, increasing demand for generic drugs, and the shift toward organized retail, Indonesia’s pharmacy sector is poised for continued growth and modernization in the coming years.